Understanding Patients Perspective on Clinical Research in Indian Population
Abstract:
OBJECTIVE
To
understand patients’ perspectives on clinical research in India
DESIGN
A
questionnaire based survey was conducted in different parts of India, covering
all kind of population. Questionnaires were filled with the help of
investigators, physicians, social workers, freelancers, research professionals,
etc.
METHODS
India
is said to be the hub of clinical research. It is also equivalently important
that the population in India are well aware about the basics of clinical
research so that individuals are not treated as “guinea pigs” and the research
is conducted with full ethics and good clinical practice. The study was
undertaken to analyze the perspective and awareness of clinical research
amongst Indian population.
RESULTS
There
were 20 different parameters/data points for which the data was collected from
6122 patients across the country. As the available data is dichotomous a
dynamic analysis was done using a percentile method.
CONCLUSION
Clinical
trials in India are conducted in ethical manner but still the understanding of
patients remains ambiguous. The data concludes that awareness about clinical
research remains low. Awareness will help us bring new therapies to the market.
KEY WORDS
Clinical
trials, Indian Scenario, Awareness, Patients Perspective, Ethics, Subjects
Confidentiality
References:
1.
A.R., C. (n.d.). Clinical trials: present and
future in India. Retrieved February 2015, from Pharmainfo.net: http://www.pharmainfo.net
2.
Bhatt, A. (2006). Winds of Change - Evolution of
clinical drug trials in India. Pharma Times(38:), pp. 19-20.
3.
Bhatt, A. S. (2004, Feb 26). Indian clinical
research odyssey. Pharma Biz(Chronicle specials). Retrieved January 2015, from http://saffron.pharmabiz.com/article/detnews.asp?articleid=20742§ionid=50
4.
Bindra, S. K. (2010). Survey on perceptions of
indian investigators on research ethics. Perceptives in Clinical Research, 1:,
94-7.
5.
Das, N. (n.d.). Outsourcing clinical trials to
India. Chillibreeze Solutions Pvt. Ltd. Retrieved February 2015, from http://www.chillibreeze.com
6.
De, M. (2005). India, ideal destination for
clinical trials. Curr Sci, 89:597.
7.
Fenn, C. W. (2001). The contemporary situation
for the conduct of clinical trials in Asia. Int J Pharm Med(15:), 169-73.
8.
Jayasheel, B. (2010). Issues regarding delay in
regulatory approvals carrying out clinical trials in India. Regulatory Affairs
Journal Pharma, 1-4.
9.
Moin, D. (2013). Clinical trials and safety
reporting under Schedule Y. Retrieved February 2015, from Pharmabiz: http://www.pharmabiz.com.
10. N., V. (2006, June 1).
Conducting clinical trials in Asia. Retrieved February 2015, from http://www.actmagazine.com
11. Parikh RM, G. M.
(2011;). Trend of clinical drug trials in type 2 DM over last decade. Percept
Clin Res, 2:, 64-6.
12. Research and Markets.
(2006). India: pharmaceutical and biotechnology opportunities. India:
Pharmalicensing Ltd. Retrieved January 2015, from http://www.researchandmarkets.com
